If you previously took Zantac and developed subsequent health problems, you may be entitled to pursue legal action for compensation. Not everyone who has side effects will be eligible to bring a successful lawsuit, which is why it’s crucial to understand who actually qualifies for the Zantac lawsuit. The FDA issued a warning that Zantac and its generic form...
Continue ReadingThe popular stomach acid and heartburn medication, Zantac, has been linked to a notable increase in cancer risk. In 2020, the FDA recalled ranitidine, the generic name for Zantac and other over-the-counter stomach acid-blocking drugs. However, by that time, millions of Americans had potentially been exposed to a deadly carcinogen. Today, Zantac class action lawsuit attorneys across the country...
Continue ReadingThe drug, Zantac, manufactured and distributed by Sanofi, is the subject of a great deal of recent public scrutiny and litigation. Zantac is said to have caused cancer in thousands of Americans who took the drug. As a result, the injured parties are pushing back. With the ongoing lawsuits against Sanofi regarding the prescription medication, many people who took...
Continue ReadingMay 11, 2021 — Manufacturer Sanofi destroyed internal emails linked to a 2019 recall of Zantac, according to lawyers for over 70,000 former patients who sued the company in the U.S. The deleted emails, including those of Michael Bailey, the head of regulatory affairs for Sanofi’s U.S. Consumer Healthcare division, will make it more challenging for plaintiffs to show...
Continue ReadingA judge recently ruled that pharmaceutical company Merck & Co must release its email exchanges concerning its shingles vaccine, Zostavax. More than 1,800 lawsuits filed against Merck & Co combined into a multidistrict litigation, and the plaintiffs accuse the company of changing label information on their vaccine. Plaintiffs claim this caused them severe injuries. It has yet to be...
Continue ReadingMultiple lawsuits are outstanding against Johnson & Johnson Pharmaceuticals and Janssen Pharmaceuticals after patients taking Elmiron developed permanent retinal injuries. Elmiron, which is used to treat interstitial cystitis, is also known as pentosan polysulfate sodium (PPS). Individuals currently taking Elmiron should obtain an eye examination. The pharmaceutical companies have yet to release a statement on the apparent connection between...
Continue ReadingNieraj Jain, MD., recently warned opthamologists of the link between a pentosan polysulfate sodium and a vision-threatening maculopathy. The drug, currently sold under the name Elmiron by Janssen Pharmaceuticals, can cause the maculopathy to appear to be age related. Dr. Jain’s research also indicates that the longer the Elmiron is used, the more likely it is to cause a...
Continue ReadingMay 5, 2021 — Plaintiffs in the Zantac multidistrict litigation are utilizing the U.S. Supreme Court’s recent ruling in Ford Motor Co v. Montana Eighth District. The March 25 decision in the Ford case held that state courts in Montana and Minnesota had jurisdiction over product liability claims against Ford despite the company not directly selling the defective vehicles...
Continue ReadingAlthough the FDA removed an amputation warning on Invokana’s box in 2020, the drug is still subject to active litigation. Although the amputation risk while taking the diabetes drug is lower than scientists initially thought, Invokana can still pose serious risks of developing Fournier’s Gangrene. Between 2013 and 2019, 21 cases of FG were reported among Invokana users. However,...
Continue ReadingMarch 6, 2021 – There have been many pretrial orders entered over the past few months in the Zantac/Ranitidine Multi-District Litigation (MDL) as referenced below. This list will continue to be amended as new orders are entered. The orders can also be found here: https://www.flsd.uscourts.gov/zantac. March 2021 March 5: Zantac Lawsuit MDL Pretrial Order # 61 – Order on...
Continue Reading